Drugs / hCG
last change Aug 2023 re-read 2 minutes ago

hCG

Developed for
hypogonadism, male · hypogonadotropic hypogonadism

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05205837 Comparator Nov 2021 → Aug 2023 hypogonadism, male, hypogonadotropic hypogonadism Rigshospitalet, Denmark Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as hCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT05205837
Route Intramuscular intramuscular injections with either hCG, initial dose 1500 IE twice weekly (letrozole group) or isotonic saline twice weekly” NCT05205837